|
After access into the right femoral vein with the avanti sheath, the physician was removing the sheath dilator and when he removed the dilator, the back portion of the introducer sheath was removed as well leaving the proximal portion of the sheath floating in the patient's body.The patient went through a lengthy procedure to retrieve the remainder of the sheath.The initial procedure that the patient was originally scheduled for (afib ablation), which was aborted due to the time spent on the sheath retrieval.The damaged sheath and the piece that was retrieved were not saved.Additional information was requested but no additional information was available.
|
|
After further review of additional information received the following sections have been updated accordingly: g3, g6, h1, h2, h3, h6, and h10.Note all the requested information has been attached under attachments.After access into the right femoral vein with an avanti sheath, the physician was removing the sheath dilator.When he removed the dilator, the back portion of the introducer sheath was removed as well leaving the proximal portion of the sheath floating in the patient's body.The patient went through a lengthy procedure to retrieve the remainder of the sheath.The initial procedure the patient was originally scheduled for (afib ablation) was aborted due to the time spent on the sheath retrieval.The product was not returned for analysis.A product history record (phr) review of lot 18054599 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.Without the return of the device or images for analysis, the reported customer event ¿catheter sheath introducer (csi)- separated - in patient¿ could not be confirmed.Vessel characteristics or insertion difficulties resulting in damage the csi are possible causes of the separation, which was noted on withdrawal.Users are trained to inspect for signs of damage prior to and during use.Any product with damage is not to be used.Information for safety is provided in the products labeling with the intent to make the user aware of the risks.According to the instructions for use (ifu), although not intended as a mitigation of risk, ¿if increased resistance is felt upon insertion of the csi, or an intravascular device through the csi, investigate the cause before continuing.If the cause cannot be determined and corrected, discontinue the procedure, and withdraw the csi.¿ based on the information available and the phr review, there is no indication that the event is related to the device design or manufacturing process.Therefore, no preventative or corrective actions will be taken at this time.
|